Persistence of occult metastatic cells in bone marrow after adjuvant systemic therapy predicts relapse in localized breast cancer.

被引：0
|
作者：
Bermejo, B
Lluch, A
Benet, I
Sastre, JM
Ferrer, JV
Garcia, T
Chumbes, L
Martinez, P
Garcia-Conde, J
机构：
[1] Hosp Clin, Dept Hematol & Oncol, Valencia, Spain
[2] Univ Valencia, Dept Stat, E-46003 Valencia, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
657
引用
收藏
页码：41S / 41S
页数：1
相关论文
共 50 条
  • [1] Persistence of occult metastatic cells in bone marrow of breast cancer patients despite systemic adjuvant treatment.
    Janni, WJ
    Strobl, B
    Schindlbeck, C
    Rjosk, D
    Kentenich, C
    Stephan, B
    Harald, S
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 214 - 214
  • [2] Occult metastatic cells in bone marrow of patients with breast and gastrointestinal cancer: Implications for adjuvant therapy
    Braun, S
    Auer, M
    Rosenberg, R
    ACTA MEDICA AUSTRIACA, 2002, 29 : 18 - 26
  • [3] Time to metastatic relapse and breast cancer cells dissemination in bone marrow at metastatic relapse
    François-Clément Bidard
    Anne Vincent-Salomon
    Brigitte Sigal-Zafrani
    Manuel Rodrigues
    Véronique Diéras
    Laurent Mignot
    Xavier Sastre-Garau
    Marie-France Poupon
    Jean-Yves Pierga
    Clinical & Experimental Metastasis, 2008, 25 : 871 - 875
  • [4] Time to metastatic relapse and breast cancer cells dissemination in bone marrow at metastatic relapse
    Bidard, Francois-Clement
    Vincent-Salomon, Anne
    Sigal-Zafrani, Brigitte
    Rodrigues, Manuel
    Dieras, Veronique
    Mignot, Laurent
    Sastre-Garau, Xavier
    Poupon, Marie-France
    Pierga, Jean-Yves
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 (08) : 871 - 875
  • [5] Clinical significance of occult metastatic cells in bone marrow of breast cancer patients
    Braun, S
    Pantel, K
    ONCOLOGIST, 2001, 6 (02): : 125 - 132
  • [6] Persistence of isolated tumor cells (ITC) in bone marrow (BM) of breast cancer patients predicts increased risk for relapse
    Janni, W
    Rack, B
    Schindlbeck, C
    Sommer, H
    Gerber, B
    Heinrigs, A
    Braun, S
    Strobl, B
    Pantel, K
    Friese, K
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S227 - S227
  • [7] Persistence of isolated tumor cells (ITC) in bone marrow (BM) of breast cancer patients predicts increased risk for relapse
    不详
    BREAST, 2005, 14 : S26 - S26
  • [8] Persistence of isolated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse - a European pooled analysis
    Naume, B.
    Fehm, T.
    Wiedswang, G.
    Juecksock, J.
    Borgen, E.
    Rack, B.
    Synnestvedt, M.
    Braun, S.
    Sommer, H.
    Solomayer, E.
    Pantel, K.
    Friese, K.
    Janni, W.
    CANCER RESEARCH, 2009, 69 (02) : 90S - 90S
  • [9] Zoledronic acid as adjuvant therapy for women with early stage breast cancer and occult tumor cells in bone marrow.
    Lin A
    Park J
    Melisko M
    Goga A
    Moasser M
    Moore D
    Brissaud C
    Rugo H
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S40 - S40
  • [10] Recent advances in technologies for the detection of occult metastatic cells in bone marrow of breast cancer patients
    Stephan Braun
    Nadia Harbeck
    Breast Cancer Research, 3
12345